| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 12826145 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 203 journal articles in the PubMed database | Email to a friend | | |
| Carnahan W, Cooper TY
Neoral-to-Gengraf conversion in renal transplant recipients. [Clinical Trial, Controlled Clinical Trial, Journal Article]
Transplant Proc 2003 Jun; 35(4):1308-13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Qazi YA, Forrest A, Tornatore K, et al.
The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function. [Journal Article]
Clin Transplant 2006 May; 20(3):313-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Roza A, Tomlanovich S, Merion R, et al.
Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation. [Clinical Trial, Controlled Clinical Trial, Journal Article, Multicenter Study]
Transplantation 2002 Oct 15; 74(7):1013-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sayyah M, Argani H, Pourmand GH, et al.
Pharmacokinetics, efficacy, and safety of iminoral compared with neoral in healthy volunteers and renal transplant recipients. [Journal Article]
Transplant Proc 2007 May; 39(4):1214-8.
Abstract | Full Citation | | Steinberg SM, Venuto RC, Kuruvila CK, et al.
Randomized, open-label preference study of two cyclosporine capsule formulations (usp modified) in stable solid-organ transplant recipients. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2003 Jul; 25(7):2037-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Taber DJ, Baillie GM, Ashcraft EE, et al.
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? [Journal Article]
Transplantation 2005 Dec 15; 80(11):1633-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Al Wakeel JS, Shaheen FA, Mathew MC, et al.
Six-month clinical outcome of cyclosporine microemulsion formulation (sigmasporin microral) in stable renal transplant patients previously maintained on sandimmun neoral. [Journal Article]
Transplant Proc 2008 Sep; 40(7):2245-51.
Abstract | Full Citation | Find Related Articles | | Johnston A, Belitsky P, Frei U, et al.
Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients. [Journal Article, Review]
Eur J Clin Pharmacol 2004 Aug; 60(6):389-95.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Taesch S, Niese D
Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients. [Clinical Trial, Comparative Study , Journal Article, Randomized Controlled Trial]
Transpl Int 1994.:S263-6.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
